On August 5, 2021, Genomictree Inc. (KOSDAQ:A228760) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20,850 KRW | +0.24% | -1.42% | +1.21% |
2023 | Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.21% | 365M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- A228760 Stock
- News Genomictree Inc.
- Genomictree Inc. announced that it has received KRW 5.00000105 billion in funding from ORION Holdings Corp.